Trial of Family Focused Grief Therapy in Palliative Care and Bereavement
Status: | Active, not recruiting |
---|---|
Conditions: | Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 12 - Any |
Updated: | 12/6/2018 |
Start Date: | November 2005 |
End Date: | December 2019 |
Randomized Controlled Trial of Family Focused Grief Therapy in Palliative Care and Bereavement
The purpose of this study is to learn how well family therapy works if given while a family
member is being treated for a serious illness and whether it helps their family to continue
meeting for a time after their death. The therapy aims to assist the family communication and
support during both palliative care and bereavement. The investigators also want to learn how
many family therapy sessions spread out over time are best for helping patients and their
families.
Patients are randomly assigned to one of three groups: patients who receive standard
palliative care, patients and their families who take part in 6 sessions, and patients and
their families who take part in 10 sessions.
member is being treated for a serious illness and whether it helps their family to continue
meeting for a time after their death. The therapy aims to assist the family communication and
support during both palliative care and bereavement. The investigators also want to learn how
many family therapy sessions spread out over time are best for helping patients and their
families.
Patients are randomly assigned to one of three groups: patients who receive standard
palliative care, patients and their families who take part in 6 sessions, and patients and
their families who take part in 10 sessions.
This Randomized Controlled Trial (RCT) seeks to test the efficacy and dose responsiveness of
a manualized family therapy intervention called Family Focused Grief Therapy (FFGT), which is
delivered to families of patients with advanced disease and continued into bereavement.
Randomization is to three arms: 6 sessions of FFGT, 10 sessions of FFGT, or standard care.
The study also explores the potential mediators of effective outcome, empowering further
refinement of the intervention, and undertakes an analysis of health-related costs of
bereavement care. It is a multi-site study involving Memorial Hospital for Cancer and Allied
Diseases (a comprehensive cancer center), Calvary Hospital (a dedicated palliative care
hospital with home hospice care program)and Beth Israel (a medical center with a dedicated
pain and palliative care department. Consenting families will be assessed at baseline through
completion of questionnaires that appraise each individual's psychosocial well-being and
perception of their family's functioning. Therapy will be delivered by family therapists
(social workers, psychologists, and psychiatrists), who will attend regular supervision
sessions to sustain fidelity of the model of intervention. Follow-up of family members for
psychosocial well-being, perceptions of family functioning, and costs of heath-related care
will occur at 3, 6, 9, & 13 months after the patient's death or completion of therapy
sessions.
a manualized family therapy intervention called Family Focused Grief Therapy (FFGT), which is
delivered to families of patients with advanced disease and continued into bereavement.
Randomization is to three arms: 6 sessions of FFGT, 10 sessions of FFGT, or standard care.
The study also explores the potential mediators of effective outcome, empowering further
refinement of the intervention, and undertakes an analysis of health-related costs of
bereavement care. It is a multi-site study involving Memorial Hospital for Cancer and Allied
Diseases (a comprehensive cancer center), Calvary Hospital (a dedicated palliative care
hospital with home hospice care program)and Beth Israel (a medical center with a dedicated
pain and palliative care department. Consenting families will be assessed at baseline through
completion of questionnaires that appraise each individual's psychosocial well-being and
perception of their family's functioning. Therapy will be delivered by family therapists
(social workers, psychologists, and psychiatrists), who will attend regular supervision
sessions to sustain fidelity of the model of intervention. Follow-up of family members for
psychosocial well-being, perceptions of family functioning, and costs of heath-related care
will occur at 3, 6, 9, & 13 months after the patient's death or completion of therapy
sessions.
Inclusion Criteria:
Subject/Patient Inclusion Criteria
- Individuals with advanced disease/Stage 4-IV cancer who may be involved in palliative
care treatment program.
- Individuals with a poor prognosis Patient and Family Member Inclusion Criteria.
- Per investigator's judgment participants must have satisfactory cognitive functioning
to provide valid informed consent and participate in family therapy.
- In the event that the index family member is declining or too frail to take part in
family meetings, the family is able to participate without the index patient being
involved in the study.
- For every enrolled family there must be at least 2 family members willing/able to take
part at the time of recruitment.
- The presence of FRI screening scores of ≤ 9 or cohesiveness subscale score < 4 based
on the perception of any single family member, including the patient.
Exclusion Criteria:
- Inability through language to complete the study questionnaires - inability to speak
English with an English-speaking therapist.
- Age less than 12 years old for a child.
- Patient and family member determined geographical inaccessibility to attend family
sessions.
- Significant psychiatric disturbance sufficient, in the investigator's judgment, to
preclude participation in a psychotherapeutic intervention.
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials